These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2431221)

  • 1. ras gene alterations and enhanced levels of ras p21 expression in a spectrum of benign and malignant human mammary tissues.
    Thor A; Ohuchi N; Hand PH; Callahan R; Weeks MO; Theillet C; Lidereau R; Escot C; Page DL; Vilasi V
    Lab Invest; 1986 Dec; 55(6):603-15. PubMed ID: 2431221
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitation of Harvey ras p21 enhanced expression in human breast and colon carcinomas.
    Hand PH; Vilasi V; Thor A; Ohuchi N; Schlom J
    J Natl Cancer Inst; 1987 Jul; 79(1):59-65. PubMed ID: 3298786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical study of the ras oncogene expression in human breast lesions.
    Agnantis NJ; Petraki C; Markoulatos P; Spandidos DA
    Anticancer Res; 1986; 6(5):1157-60. PubMed ID: 3541779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced expression of c-Ha-ras p21 in human stomach adenocarcinomas defined by immunoassays using monoclonal antibodies and in situ hybridization.
    Ohuchi N; Hand PH; Merlo G; Fujita J; Mariani-Costantini R; Thor A; Nose M; Callahan R; Schlom J
    Cancer Res; 1987 Mar; 47(5):1413-20. PubMed ID: 2434216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the 21,000 molecular weight ras protein in a spectrum of benign and malignant human mammary tissues.
    Ohuchi N; Thor A; Page DL; Hand PH; Halter SA; Schlom J
    Cancer Res; 1986 May; 46(5):2511-9. PubMed ID: 3084069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneous immunoreactivity of frozen human benign and malignant breast lesions to C-MYC and C-Ha-ras cellular oncogenes.
    Pechoux C; Chardonnet Y; Chignol MC; Noël P
    Histol Histopathol; 1994 Jan; 9(1):35-44. PubMed ID: 8003818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated oncogenes in human skin tumors from a repair-deficient syndrome, xeroderma pigmentosum.
    Suarez HG; Daya-Grosjean L; Schlaifer D; Nardeux P; Renault G; Bos JL; Sarasin A
    Cancer Res; 1989 Mar; 49(5):1223-8. PubMed ID: 2645047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
    Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
    Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing sequential oncogene amplification in human breast cancer.
    Janocko LE; Lucke JF; Groft DW; Brown KA; Smith CA; Pollice AA; Singh SG; Yakulis R; Hartsock RJ; Shackney SE
    Cytometry; 1995 Sep; 21(1):18-22. PubMed ID: 8529465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human malignant tumours of the breast, as compared to their respective normal tissue, have elevated expression of the Harvey ras oncogene.
    Spandidos DA; Agnantis NJ
    Anticancer Res; 1984; 4(4-5):269-72. PubMed ID: 6207764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of ras and myc oncogenes in human hepatocellular carcinoma and non-neoplastic liver tissues.
    Tiniakos D; Spandidos DA; Kakkanas A; Pintzas A; Pollice L; Tiniakos G
    Anticancer Res; 1989; 9(3):715-21. PubMed ID: 2548435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of p21 ras oncoproteins in human cancers.
    Tanaka T; Slamon DJ; Battifora H; Cline MJ
    Cancer Res; 1986 Mar; 46(3):1465-70. PubMed ID: 3510727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of a c-H-ras-1 allele and aggressive human primary breast carcinomas.
    Theillet C; Lidereau R; Escot C; Hutzell P; Brunet M; Gest J; Schlom J; Callahan R
    Cancer Res; 1986 Sep; 46(9):4776-81. PubMed ID: 3524819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of oncogenes in human neoplasia.
    Aaronson SA; Tronick SR
    Important Adv Oncol; 1985; ():3-15. PubMed ID: 3916746
    [No Abstract]   [Full Text] [Related]  

  • 15. [Joint amplification of c-myc and c-Ha-ras oncogenes in human breast and thyroid cancer cells].
    Pluzhnikova GF; Serova OM; Kniazev PG; Fedorov SN; Novikov LB
    Eksp Onkol; 1987; 9(2):15-7. PubMed ID: 3034547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High levels of c-myc protein in human breast tumours determined by a sensitive ELISA technique.
    Spandidos DA; Field JK; Agnantis NJ; Evan GI; Moore JP
    Anticancer Res; 1989; 9(4):821-6. PubMed ID: 2683996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of the expression of a ras protein with a molecular weight of 21,000 by human breast cancer.
    Clair T; Miller WR; Cho-Chung YS
    Cancer Res; 1987 Oct; 47(20):5290-3. PubMed ID: 3308076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ras, c-myc and c-erbB-2 oncoproteins in human breast cancer.
    Spandidos DA; Yiagnisis M; Papadimitriou K; Field JK
    Anticancer Res; 1989; 9(5):1385-93. PubMed ID: 2574023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
    Spandidos DA
    Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of activated ras oncogenes in human thyroid carcinomas.
    Suárez HG; Du Villard JA; Caillou B; Schlumberger M; Tubiana M; Parmentier C; Monier R
    Oncogene; 1988 Apr; 2(4):403-6. PubMed ID: 3283656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.